Two classes of DNA gyrase inhibitors elicit distinct evolutionary trajectories toward resistance in gram-negative pathogens

Semen A. Leyn(Agilent Technologies (United States)), Andrei L. Osterman(Sanford Burnham Prebys Medical Discovery Institute)
npj Antimicrobials and Resistance
March 2, 2024
Cited by 12


Related Papers